Abstract

Finding novel biomarkers for human pathologies and predicting clinical outcomes for patients is challenging. This stems from the heterogeneous response of individuals to disease and is reflected in the inter-individual variability of gene expression responses that obscures differential gene expression analysis. Here, we developed an alternative approach that could be applied to dissect the disease-associated molecular changes. We define gene ensemble noise as a measure that represents a variance for a collection of genes encoding for either members of known biological pathways or subunits of annotated protein complexes and calculated within an individual. The gene ensemble noise allows for the holistic identification and interpretation of gene expression disbalance on the level of gene networks and systems. By comparing gene expression data from COVID-19, H1N1, and sepsis patients we identified common disturbances in a number of pathways and protein complexes relevant to the sepsis pathology. Among others, these include the mitochondrial respiratory chain complex I and peroxisomes. This suggests a Warburg effect and oxidative stress as common hallmarks of the immune host–pathogen response. Finally, we showed that gene ensemble noise could successfully be applied for the prediction of clinical outcome namely, the mortality of patients. Thus, we conclude that gene ensemble noise represents a promising approach for the investigation of molecular mechanisms of pathology through a prism of alterations in the coherent expression of gene circuits.

Highlights

  • Finding novel biomarkers for human pathologies and predicting clinical outcomes for patients is challenging

  • We identified a number of pathways for which gene ensemble noise associated positively with an individual health/disease state or mortality risk when treated as an ordinal variable (healthy < early H1N1 phase < late H1N1 phase, healthy < sepsis (CAP, other) survived < sepsis (CAP, other) deceased patients, and less-severe < severe COVID-19)

  • We attempted a dissection of molecular mechanisms of human pathology, exemplified by SARS-CoV-2 and H1N1 infection, and sepsis, through a prism of gene ensemble noise

Read more

Summary

Introduction

Finding novel biomarkers for human pathologies and predicting clinical outcomes for patients is challenging This stems from the heterogeneous response of individuals to disease and is reflected in the inter-individual variability of gene expression responses that obscures differential gene expression analysis. A canonical approach for the identification of disease biomarkers and their potential therapeutic targets relies on differential gene expression (DGE) analysis either on RNA or protein levels. This stems from a classical gene regulation Jacob-Monod model, which implies a specific gene expression response (up- or down-regulation) to a specific signal (see the recent perspective on historical origins of the ­model[16]). These genes are tightly-regulated and any fluctuations in their expression might be causative for a diseased state

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call